Natural MedTech
Also known as: Natural MedTech Pty Ltd
Data updated
Enterprise Intelligence
Quarterly psychedelic drug-development briefing
Compare indication activity, programme milestones, competitive intensity, and near-term catalysts. Q2 includes quarter-over-quarter changes against the published Q1 baseline.
Natural MedTech Pty Ltd is an Australian manufacturer of active pharmaceutical ingredients, founded in 2021, that uses biosynthesis (precision fermentation) to produce psychedelic APIs. It is the only manufacturer of psilocybin and MDMA APIs in Australia, holding Schedule 8 and Schedule 9 cGMP manufacturing licences and complying with TGO 112 and TGO 113. Natural MedTech supplies both API and finished dose forms, has supported more than ten Phase 2 or later clinical trials in Australia and internationally, and runs a sustainable process that avoids petrochemicals, harsh solvents and plastic waste. Supply is via authorised professional and clinical-trial channels only.
Manufacturing Snapshot
Psychedelic-Focused ManufacturerScope & Capabilities
Supply Use Cases
GxP / Compliance
Facilities & Access
Australian cGMP facility producing psychedelic APIs via biosynthesis (precision fermentation), with direct supply to authorised professional and clinical-trial channels.
Capacity Notes
Sustainable, solvent-free biosynthesis process (no petrochemicals, harsh solvents or plastic waste).
Supported Substances
Psilocybin and MDMA APIs and finished dose forms; described as the only psilocybin and MDMA API manufacturer in Australia, having supported 10+ Phase 2 or later clinical trials in Australia and globally.
Regulatory Authorizations
1 authorizationAustralia - Therapeutic Goods Administration (TGA)
ActiveSchedule 8 and Schedule 9 cGMP manufacturing licences
TGO 112 and TGO 113 compliant
View sourceManufacturing Sources
Ecosystem
1 connectionInvestors
Documented relationship
Jan 1, 2021
Quick Facts
- Founded
- 2021
- HQ
- Australia, Australia
- Website
- Visit